Advertisement

Pediatric rheumatology in Turkey

  • Amra Adrovic
  • Ozgur KasapcopurEmail author
Review
  • 68 Downloads

Abstract

Pediatric Rheumatology is an emerging specialty in Turkey with increasing number of available centers and specialists all over the country. In this paper, we sought to provide an overview on pediatric rheumatology service in our country, as well as to assess the principle published literature from Turkey in this field. A systematic literature search has been performed to achieve the significance and the impact of this manuscript. The most relevant used databases (PubMed/MEDLINE, Web of Science, SCOPUS) for peer-reviewed studies and reviews in English language published during the last 5 years were screened. In the first part of the manuscript, we tried to give more details on the history of pediatric rheumatology in Turkey. In further text, we put an accent over the most common rheumatologic conditions among children in Turkey, including Familial Mediterranean fever, juvenile idiopathic arthritis, juvenile spondyloarthropathies, and childhood vasculitides. Despite the considerable literature from Turkey on pediatric rheumatic diseases, a need for unique strategies that would guide the management of rheumatic diseases in childhood remains open. The cultural and historical inheritance together with geographical position make the Turkey a suitable ground for investigations in filed of auto-inflammation and all other inflammatory conditions. Prospective, multicentric studies especially among rheumatologic conditions common in this part of the world would give us more relevant data and open new horizons in diseases’ management. International collaborations and databases should be highly encouraged and supported, to make the care of pediatric rheumatic disease uniform.

Keywords

Familial Mediterranean fever Juvenile idiopathic arthritis Spondyloarthropathies Pediatric rheumatology Turkey 

Notes

Funding

No funding was received for this study.

Compliance with ethical standards

Conflict of interest

None of the authors of this paper has a conflict of interest, including specific financial interests, relationships and/or affiliations relevant to the subject matter or materials included.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

References

  1. 1.
    Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD (2011) Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int 31:1409–1417Google Scholar
  2. 2.
    Imamoglu A, Ozen S (1988) Epidemiology of rheumatic heart disease. Arch Dis Child 63:1501–1503Google Scholar
  3. 3.
    Ozdogan H, Turunç M, Deringöl B, Yurdakul S, Yazici H (1986) Sulphasalazine in the treatment of juvenile rheumatoid arthritis: a preliminary open trial. J Rheumatol 13:124–125Google Scholar
  4. 4.
    Ozdogan H, Kasapçopur O, Dede H, Arisoy N, Beceren T, Yurdakul S, Yazici H (1991) Juvenile chronic arthritis in a Turkish population. Clin Exp Rheumatol 9:431–435Google Scholar
  5. 5.
    Ozdogan H, Arisoy N, Kasapçapur O, Sever L, Calişkan S, Tuzuner N, Mat C, Yazici H (1997) Vasculitis in familial Mediterranean fever. J Rheumatol 24:323–327Google Scholar
  6. 6.
    Ozdogan H, Ruperto N, Kasapçopur O, Bakkaloglu A, Arisoy N, Ozen S, Ugurlu U, Unsal E, Melikoglu M, Paediatric Rheumatology International Trials Organisation (2001) The Turkish version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ). Clin Exp Rheumatol 19(4 Suppl 23):S158–S162Google Scholar
  7. 7.
    Barut K, Sahin S, Adrovic A, Sinoplu AB, Yucel G, Pamuk G, Aydın AK, Dasdemir S, Turanlı ET, Buyru N, Kasapcopur O (2018) Familial Mediterranean fever in childhood: a single-center experience. Rheumatol Int 38:67–74Google Scholar
  8. 8.
    Barut K, Pamuk G, Adrovic A, Şahin S, Kaplan A, Güler M, Kasapçopur Ö (2018) Comparison of familial Mediterranean fever and juvenile idiopathic arthritis patients according to family origin. Turk Pediatri Ars 53:31–36Google Scholar
  9. 9.
    Tunca M, Akar S, Onen F, Ozdogan H, Kasapcopur O, Yalcinkaya F, Tutar E, Ozen S, Topaloglu R, Yilmaz E, Arici M, Bakkaloglu A, Besbas N, Akpolat T, Dinc A, Erken E, Turkish, FMF Study Group (2005) Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine 84:1–11Google Scholar
  10. 10.
    Yalçinkaya F, Ozen S, Ozçakar ZB, Aktay N, Cakar N, Düzova A, Kasapçopur O, Elhan AH, Doganay B, Ekim M, Kara N, Uncu N, Bakkaloglu A (2009) A new set of criteria for the diagnosis of familial Mediterranean fever in childhood. Rheumatology 48:395–398Google Scholar
  11. 11.
    Yilmaz E, Ozen S, Balci B, Duzova A, Topaloglu R, Besbas N, Saatci U, Bakkaloglu A, Ozguc M (2001) Mutation frequency of Familial Mediterranean Fever and evidence for a high carrier rate in the Turkish population. Eur J Hum Genet 9:553–555Google Scholar
  12. 12.
    Makay B, Gülez N (2018) Long-term follow-up of paediatric MEFV carriers. Clin Rheumatol 37:1683–1687Google Scholar
  13. 13.
    Özdel S, Özçakar ZB, Kunt S, Elhan AH, Yalçınkaya F (2016) Late-onset disease is associated with a mild phenotype in children with familial Mediterranean fever. Clin Rheumatol 35:1837–1840Google Scholar
  14. 14.
    Sönmez HE, Esmeray P, Batu ED, Arıcı ZS, Demir S, Sağ E, Özen S, Bilginer Y (2018) Is age associated with disease severity and compliance to treatment in children with familial Mediterranean fever?. Rheumatol Int 5:1–5 (Epub ahead of print) Google Scholar
  15. 15.
    Özkan E, Okur Ö, Ekmekçi A, Özcan R, Tağ T (1972) A new approach to the treatment of periodic fever. Med Bull İstanbul 5:44–49Google Scholar
  16. 16.
    Saatçi U, Ozen S, Ozdemir S, Bakkaloglu A, Besbas N, Topaloglu R, Arslan S (1997) Familial Mediterranean fever in children: report of a large series and discussion of the risk and prognostic factors of amyloidosis. Eur J Pediatr 156:619–623Google Scholar
  17. 17.
    Erden A, Batu ED, Sarı A, Sönmez HE, Armagan B, Demir S, Fırat E, Bilginer Y, Bilgen SA, Karadağ Ö, Kalyoncu U, Kiraz S, Ertenli I, Özen S, Akdogan A (2018) Which definition should be used to determine colchicine resistance among patients with familial Mediterranean fever? Clin Exp Rheumatol 36(Suppl 115):97–102Google Scholar
  18. 18.
    Özçakar ZB, Özdel S, Yılmaz S, Kurt-Şükür ED, Ekim M, Yalçınkaya F (2016) Anti-IL-1 treatment in familial Mediterranean fever and related amyloidosis. Clin Rheumatol 35:441–446Google Scholar
  19. 19.
    Yazılıtaş F, Aydoğ Ö, Özlü SG, Çakıcı EK, Güngör T, Eroğlu FK, Gür G, Bülbül M (2018) Canakinumab treatment in children with familial Mediterranean fever: report from a single center. Rheumatol Int 38:879–885Google Scholar
  20. 20.
    Gül A, Ozdogan H, Erer B, Ugurlu S, Kasapcopur O, Davis N, Sevgi S (2015) Efficacy and safety of canakinumab in adolescents and adults with colchicine-resistant familial Mediterranean fever. Arthritis Res Ther 17:243Google Scholar
  21. 21.
    Eroglu FK, Beşbaş N, Topaloglu R, Ozen S (2015) Treatment of colchicine-resistant Familial Mediterranean fever in children and adolescents. Rheumatol Int 35:1733–1737Google Scholar
  22. 22.
    De Benedetti F, Gattorno M, Anton J, Ben-Chetrit E, Frenkel J, Hoffman HM, Koné-Paut I, Lachmann HJ, Ozen S, Simon A, Zeft A, Calvo Penades I, Moutschen M, Quartier P, Kasapcopur O, Shcherbina A, Hofer M, Hashkes PJ, Van der Hilst J, Hara R, Bujan-Rivas S, Constantin T, Gul A, Livneh A, Brogan P, Cattalini M, Obici L, Lheritier K, Speziale A, Junge G (2018) Canakinumab for the treatment of autoinflammatory recurrent fever syndromes. N Engl J Med 378:1908–1919Google Scholar
  23. 23.
    Gülez N, Makay B, Sözeri B (2018) Long-term effectiveness and safety of canakinumab in pediatric Familial Mediterranean fever patients. Mod Rheumatol 17:1–13Google Scholar
  24. 24.
    Nalcacioglu H, Ozkaya O, Genc G, Ayyildiz S, Kefeli M, Elli M, Aydin O, Ceyhan Bilgici M (2018) Efficacy of anakinra in a patient with systemic amyloidosis presenting as amyloidoma. Int J Rheum Dis 21:552–559Google Scholar
  25. 25.
    Barut K, Adrovic A, Şahin S, Kasapçopur Ö (2017) Juvenile idiopathic arthritis. Balkan Med J 34:90–101Google Scholar
  26. 26.
    Ozen S, Karaaslan Y, Ozdemir O, Saatci U, Bakkaloglu A, Koroglu E, Tezcan S (1998) Prevalence of juvenile chronic arthritis and familial Mediterranean fever in Turkey: a field study. J Rheumatol 25:2445–2449Google Scholar
  27. 27.
    Cakan M, Aktay-Ayaz N, Keskindemirci G, Ekinci DY, Karadağ ŞG (2017) Subtype frequencies, demographic features, and remission rates in juvenile idiopathic arthritis—265 cases from a Turkish center. Turk J Pediatr 59:548–554Google Scholar
  28. 28.
    Karacan I, Uğurlu S, Şahin S, Everest E, Kasapçopur Ö, Tolun A, Özdoğan H, Turanli ET (2018) LACC1 gene defects in familial form of juvenile arthritis. J Rheumatol 45:726–728Google Scholar
  29. 29.
    Ombrello MJ, Arthur VL, Remmers EF, Hinks A, Tachmazidou I, Grom AA, Foell D, Martini A, Gattorno M, Özen S, Prahalad S, Zeft AS, Bohnsack JF, Ilowite NT, Mellins ED, Russo R, Len C, Hilario MO, Oliveira S, Yeung RS, Rosenberg AM, Wedderburn LR, Anton J, Haas JP, Rosen-Wolff A, Minden K, Tenbrock K, Demirkaya E, Cobb J, Baskin E, Signa S, Shuldiner E, Duerr RH, Achkar JP, Kamboh MI, Kaufman KM, Kottyan LC, Pinto D, Scherer SW, Alarcón-Riquelme ME, Docampo E, Estivill X, Gül A, British Society of Pediatric and Adolescent Rheumatology (BSPAR) Study Group, Inception Cohort of Newly Diagnosed Patients with Juvenile Idiopathic Arthritis(ICON-JIA) Study Group, Childhood Arthritis Prospective Study (CAPS) Group, Randomized Placebo Phase Study of Rilonacept in sJIA (RAPPORT) Investigators, Sparks-Childhood Arthritis Response to Medication Study (CHARMS) Group, Biologically Based Outcome Predictors in JIA (BBOP) Group, Langefeld CD, Thompson S, Zeggini E, Kastner DL, Woo P, Thomson W (2017) Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: clinical and therapeutic implications. Ann Rheum Dis 76:906–913Google Scholar
  30. 30.
    Barut K, Yücel G, Sinoplu AB, Şahin S, Adroviç A, Kasapçopur Ö (2015) Evaluation of macrophage activation syndrome associated with systemic juvenile idiopathic arthritis: single center experience over a one-year period. Turk Pediatri Ars 50:206–210Google Scholar
  31. 31.
    Batu ED (2018) Glucocorticoid treatment in juvenile idiopathic arthritis. Rheumatol Int 5:1–15. (Epub ahead of print) Google Scholar
  32. 32.
    Baris HE, Anderson E, Sozeri B, Dedeoglu F (2018) Impact of biologics on disease course in systemic onset juvenile idiopathic arthritis. Clin Rheumatol 37:3263–3273 (Epub ahead of print) Google Scholar
  33. 33.
    Sönmez HE, Demir S, Bilginer Y, Özen S (2018) Anakinra treatment in macrophage activation syndrome: a single center experience and systemic review of literature. Clin Rheumatol 6:1–7. (Epub ahead of print) Google Scholar
  34. 34.
    Tarakci E, Yeldan I, Baydogan SN, Olgar S, Kasapcopur O (2012) Efficacy of a land-based home exercise programme for patients with juvenile idiopathic arthritis: a randomized, controlled, single-blind study. J Rehabil Med 44:962–967Google Scholar
  35. 35.
    Tarakci E, Yeldan I, Kaya Mutlu E, Baydogan SN, Kasapcopur O (2011) The relationship between physical activity level, anxiety, depression, and functional ability in children and adolescents with juvenile idiopathic arthritis. Clin Rheumatol 30:1415–1420Google Scholar
  36. 36.
    Bayraktar D, Savci S, Altug-Gucenmez O, Manci E, Makay B, Ilcin N, Unsal E (2018) The effects of 8-week water-running program on exercise capacity in children with juvenile idiopathic arthritis: a controlled trial. Rheumatol Int 6:1–7. (Epub ahead of print) Google Scholar
  37. 37.
    Unal E, Batu ED, Sonmez HE, Arici ZS, Arin G, Karaca NB, Sag E, Demir S, Hakli DA, Ozcadirci A, Oflaz FB, Alpar R, Bilginer Y, Ozen S (2018) A new biopsychosocial and clinical questionnaire to assess juvenile idiopathic arthritis: JAB-Q. Rheumatol Int 38:1557–1564Google Scholar
  38. 38.
    Demirkaya E, Ozen S, Sozeri B, Ayaz NA, Kasapcopur O, Unsal E, Makay BB, Barut K, Fidanci BE, Simsek D, Cakan M, Consolaro A, Bovis F, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO) (2018) The Turkish version of the Juvenile Arthritis Multidimensional Assessment Report. JAMAR 38(Suppl 1):395–402Google Scholar
  39. 39.
    Adrovic A, Barut K, Sahin S, Kasapcopur O (2016) Juvenile Spondyloarthropathies. Curr Rheumatol Rep 18:55Google Scholar
  40. 40.
    Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, He X, Maldonado-Cocco J, Orozco-Alcala J, Prieur AM, Suarez-Almazor ME, Woo P, International League of Associations for Rheumatology (2004) International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 31:390–392Google Scholar
  41. 41.
    Demirkaya E, Ozen S, Bilginer Y, Ayaz NA, Makay BB, Unsal E, Erguven M, Poyrazoglu H, Kasapcopur O, Gok F, Akman S, Balat A, Cavkaytar O, Kaya B, Duzova A, Ozaltin F, Topaloglu R, Besbas N, Bakkaloglu A, Arisoy N, Ozdogan H, Bakkaloglu S, Turker T (2011) The distribution of juvenile idiopathic arthritis in the eastern Mediterranean: results from the registry of the Turkish Paediatric Rheumatology Association. Clin Exp Rheumatol 29:111–116Google Scholar
  42. 42.
    Adrovic A, Sezen M, Barut K, Sahin S, Acikel C, Demirkaya E, Kasapcopur O (2017) The performance of classification criteria for juvenile spondyloarthropathies. Rheumatol Int 37:2013–2018Google Scholar
  43. 43.
    Sönmez HE, Batu ED, Demir S, Bilginer Y, Özen S (2017) Comparison of patients with familial Mediterranean fever accompanied with sacroiliitis and patients with juvenile spondyloarthropathy. Clin Exp Rheumatol 108:124–127Google Scholar
  44. 44.
    Ozer E, Seker D, Taner E, Adrovic A, Sahin S, Barut K, Kasapcopur O (2018) The frequency of juvenile spondyloarthropathies in childhood familial Mediterranean fever. Clin Exp RheumatolGoogle Scholar
  45. 45.
    Makay B, Gücenmez ÖA, Ünsal E (2016) Inactive disease in enthesitis-related arthritis: association of increased Body Mass Index. J Rheumatol 43:937–943Google Scholar
  46. 46.
    Barut K, Sahin S, Kasapcopur O (2016) Pediatric vasculitis. Curr Opin Rheumatol 28:29–38Google Scholar
  47. 47.
    Batu ED, Sarı A, Erden A, Sönmez HE, Armağan B, Kalyoncu U, Karadağ Ö, Bilginer Y, Akdoğan A, Kiraz S, Özen S (2018) Comparing immunoglobulin A vasculitis (Henoch-Schönlein purpura) in children and adults: a single-centre study from Turkey. Scand J Rheumatol 18:1–6Google Scholar
  48. 48.
    Ruperto N, Ozen S, Pistorio A, Dolezalova P, Brogan P, Cabral DA, Cuttica R, Khubchandani R, Lovell DJ, O’Neil KM, Quartier P, Ravelli A, Iusan SM, Filocamo G, Magalhães CS, Unsal E, Oliveira S, Bracaglia C, Bagga A, Stanevicha V, Manzoni SM, Pratsidou P, Lepore L, Espada G, Kone-Paut I, Zulian F, Barone P, Bircan Z, Maldonado Mdel R, Russo R, Vilca I, Tullus K, Cimaz R, Horneff G, Anton J, Garay S, Nielsen S, Barbano G, Martini A, Paediatric Rheumatology International Trials Organisation (PRINTO) (2010) EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part I: Overall methodology and clinical characterisation. Ann Rheum Dis 69:790–797Google Scholar
  49. 49.
    Ozen S, Pistorio A, Iusan SM, Bakkaloglu A, Herlin T, Brik R, Buoncompagni A, Lazar C, Bilge I, Uziel Y, Rigante D, Cantarini L, Hilario MO, Silva CA, Alegria M, Norambuena X, Belot A, Berkun Y, Estrella AI, Olivieri AN, Alpigiani MG, Rumba I, Sztajnbok F, Tambic-Bukovac L, Breda L, Al-Mayouf S, Mihaylova D, Chasnyk V, Sengler C, Klein-Gitelman M, Djeddi D, Nuno L, Pruunsild C, Brunner J, Kondi A, Pagava K, Pederzoli S, Martini A, Ruperto N, Paediatric Rheumatology International Trials Organisation (PRINTO) (2010) EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. Ann Rheum Dis 69:798–806Google Scholar
  50. 50.
    Dedeoglu R, Barut K, Oztunc F, Atik S, Adrovic A, Sahin S, Cengiz D, Kasapcopur O (2017) Evaluation of myocardial deformation in patients with Kawasaki disease using speckle-tracking echocardiography during mid-term follow-up. Cardiol Young 27:1377–1385Google Scholar
  51. 51.
    Ozen S, Batu ED (2018) Vasculitis Pathogenesis: Can We Talk About Precision Medicine? Front Immunol 9:1892Google Scholar
  52. 52.
    Garg N, Kasapcopur O, Foster J, Barut K, Tekin A, Kızılkılıç O, Tekin M (2014) Novel adenosine deaminase 2 mutations in a child with a fatal vasculopathy. Eur J Pediatr 173:827–830Google Scholar
  53. 53.
    Navon Elkan P, Pierce SB, Segel R, Walsh T, Barash J, Padeh S, Zlotogorski A, Berkun Y, Press JJ, Mukamel M, Voth I, Hashkes PJ, Harel L, Hoffer V, Ling E, Yalcinkaya F, Kasapcopur O, Lee MK, Klevit RE, Renbaum P, Weinberg-Shukron A, Sener EF, Schormair B, Zeligson S, Marek-Yagel D, Strom TM, Shohat M, Singer A, Rubinow A, Pras E, Winkelmann J, Tekin M, Anikster Y, King MC, Levy-Lahad E (2014) Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy. N Engl J Med 370:921–931Google Scholar
  54. 54.
    Zhou Q, Yang D, Ombrello AK, Zavialov AV, Toro C, Zavialov AV, Stone DL, Chae JJ, Rosenzweig SD, Bishop K, Barron KS, Kuehn HS, Hoffmann P, Negro A, Tsai WL, Cowen EW, Pei W, Milner JD, Silvin C, Heller T, Chin DT, Patronas NJ, Barber JS, Lee CC, Wood GM, Ling A, Kelly SJ, Kleiner DE, Mullikin JC, Ganson NJ, Kong HH, Hambleton S, Candotti F, Quezado MM, Calvo KR, Alao H, Barham BK, Jones A, Meschia JF, Worrall BB, Kasner SE, Rich SS, Goldbach-Mansky R, Abinun M, Chalom E, Gotte AC, Punaro M, Pascual V, Verbsky JW, Torgerson TR, Singer NG, Gershon TR, Ozen S, Karadag O, Fleisher TA, Remmers EF, Burgess SM, Moir SL, Gadina M, Sood R, Hershfield MS, Boehm M, Kastner DL, Aksentijevich I (2014) Early-onset stroke and vasculopathy associated with mutations in ADA2. N Engl J Med 370:911–920Google Scholar
  55. 55.
    Sahin S, Adrovic A, Barut K, Ugurlu S, Turanli ET, Ozdogan H, Kasapcopur O (2018) Clinical, imaging and genotypical features of three deceased and five surviving cases with ADA2 deficiency. Rheumatol Int 38:129–136Google Scholar
  56. 56.
    Batu ED, Karadag O, Taskiran EZ, Kalyoncu U, Aksentijevich I, Alikasifoglu M, Özen S (2015) A case series of adenosine deaminase 2-deficient patients emphasizing treatment and genotype-phenotype correlations. J Rheumatol 42:1532–1534Google Scholar
  57. 57.
    Kisla Ekinci RM, Balci S, Bisgin A, Hershfield M, Atmis B, Dogruel D, Yilmaz M (2018) Renal amyloidosis in deficiency of adenosine deaminase 2: successful experience with Canakinumab. Pediatrics 142:e20180948Google Scholar
  58. 58.
    Karincaoglu Y, Borlu M, Toker SC, Akman A, Onder M, Gunasti S, Usta A, Kandi B, Durusoy C, Seyhan M, Utas S, Saricaoglu H, Ozden MG, Uzun S, Tursen U, Cicek D, Donmez L, Alpsoy E (2008) Demographic and clinical properties of juvenile-onset Behçet’s disease: a controlled multicenter study. J Am Acad Dermatol 58:579–584Google Scholar
  59. 59.
    Behçet H (1937) Über rezidivierende aphtose durch ein virus verursachte geschwü ream mund, am auge und an den genitalien. Derm Wschr 105:115Google Scholar
  60. 60.
    Uluduz D, Kürtüncü M, Yapıcı Z, Seyahi E, Kasapçopur Ö, Özdoğan H, Saip S, Akman-Demir G, Siva A (2011) Clinical characteristics of pediatric-onset neuro-Behçet disease. Neurology 77:1900–1905Google Scholar
  61. 61.
    Batu ED (2018) Diagnostic/classification criteria in pediatric Behçet’s disease. Rheumatol Int. (Epub ahead of print) Google Scholar
  62. 62.
    Batu ED, Sönmez HE, Sözeri B, Butbul Aviel Y, Bilginer Y, Özen S (2017) The performance of different classification criteria in paediatric Behçet’s disease. Clin Exp Rheumatol 108:119–123Google Scholar
  63. 63.
    Koné-Paut I, Shahram F, Darce-Bello M, Cantarini L, Cimaz R, Gattorno M, Anton J, Hofer M, Chkirate B, Bouayed K, Tugal-Tutkun I, Kuemmerle-Deschner J, Agostini H, Federici S, Arnoux A, Piedvache C, Ozen S, PEDBD group (2016) Consensus classification criteria for paediatric Behçet’s disease from a prospective observational cohort: PEDBD. Ann Rheum Dis 75:958–964Google Scholar
  64. 64.
    Topcuoglu OM, Topcuoglu ED, Altay CM, Genc S (2017) Imaging pearls of pediatric Behçet’s disease. Eur J Radiol 94:115–124Google Scholar
  65. 65.
    Sahin S, Adrovic A, Barut K, Canpolat N, Ozluk Y, Kilicaslan I, Caliskan S, Sever L, Kasapcopur O (2018) Juvenile systemic lupus erythematosus in Turkey: demographic, clinical and laboratory features with disease activity and outcome. Lupus 27:514–519Google Scholar
  66. 66.
    Adrovic A, Sahin S, Barut K, Kasapcopur O (2018) Juvenile scleroderma: a referral center experience. Arch Rheumatol 33(x):i-viiiGoogle Scholar
  67. 67.
    Barut K, Aydin PO, Adrovic A, Sahin S, Kasapcopur O (2017) Juvenile dermatomyositis: a tertiary center experience. Clin Rheumatol 36:361–366Google Scholar
  68. 68.
    Artim-Esen B, Şahin S, Çene E, Şahinkaya Y, Barut K, Adrovic A, Özlük Y, Kılıçaslan I, Omma A, Gül A, Öcal L, Kasapçopur Ö, İnanç M (2017) Comparison of disease characteristics, organ damage, and survival in patients with juvenile-onset and adult-onset systemic lupus erythematosus in a combined cohort from 2 Tertiary centers in Turkey. J Rheumatol 44:619–625Google Scholar
  69. 69.
    Batu ED, Koşukcu C, Taşkıran E, Sahin S, Akman S, Sözeri B, Ünsal E, Bilginer Y, Kasapcopur O, Alikaşifoğlu M, Ozen S (2018) Whole exome sequencing in early-onset systemic lupus erythematosus. J Rheumatol. (Epub ahead of print) Google Scholar
  70. 70.
    Foeldvari I, Klotsche J, Torok SK, Kasapcopur O, Adrovic A, Stanevicha V, Terreri MT, Alexeeva E, Katsicas M, Cimaz M, KostikM, Lehman T, Sifuentes-Giraldo WA, Smith V, Sztajnbok F, Avcin T, Santos MJ, Moll M, Nemcova D, Battagliotti C, Eleftheriou D, Janarthanan M, Kallinich T, Anton J, Minden K, Nielsen S, Uziel Y, Helmus N (2018) Are diffuse and limited juvenile systemic sclerosis different in clinical presentation? Clinical characteristics of a juvenile systemic sclerosis cohort. J Scleroder and Relat Disord. (Epub ahead of print) Google Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Pediatric RheumatologyCerrahpasa Medical School, Istanbul University-CerrahpasaIstanbulTurkey

Personalised recommendations